Catherine Barry, DO
Anatomic Pathology · Charlottesville, VANPI 1730382581
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $765 of the $954 with a category attached, or 80.1%. 14 manufacturers reported payments, led by Johnson & Johnson at 28.2% of the total. Reporting peaked in 2023 at $305 and has fallen 59.2% since, to $124 in 2025.
Across 37 payments — averaging $25.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$269
- AbbVie$199
- E.r. Squibb & Sons, L.L.C.$116
- Lilly USA, LLC$99
- Sanofi$71
- Novartis$47
- plus $153 from 8 others
What the payments were for
- Food & beverage$76580%
- Education$19020%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $269 |
| AbbVie | 9 | $199 |
| E.r. Squibb & Sons, L.L.C. | 3 | $116 |
| Lilly USA, LLC | 6 | $99 |
| Sanofi | 3 | $71 |
| Novartis | 2 | $47 |
| VYNE Pharmaceuticals Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| LEO Pharma Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
| Merck | 1 | $12 |
How this compares
$954 in reported general payments places this provider in the 70th percentile of 21 anatomic pathology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 135 | $3,662 |
| Fluorouracil | 49 | $2,701 |
| Clobetasol Propionate | 40 | $1,311 |
| Nystatin | 63 | $903 |
| Triamcinolone Acetonide | 99 | $706 |
| Econazole Nitrate | 21 | $613 |
| Imiquimod | 12 | $600 |
| Terbinafine Hcl | 29 | $575 |
| Doxycycline Hyclate | 13 | $372 |
| Mupirocin | 41 | $288 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 14 | $273 |
| MethotrexateMethotrexate Sodium | 17 | $208 |
| Hydroxyzine Hcl | 13 | $197 |
| Fluconazole | 24 | $180 |
| ValacyclovirValacyclovir Hcl | 12 | $147 |
Paid to pharmacies, not to this prescriber.
Other anatomic pathology in Charlottesville
- Mark StolerCharlottesville$248K
- Sarah GradeckiCharlottesville$2K
- Anne MillsCharlottesville$157
- William GlassCharlottesville$45
- Henry BatemanCharlottesville$21
- Sara ZadehCharlottesville$16
- Zachary GoodmanFalls Church$184K
- Haresh ManiFalls Church$11K
- Steven SmithRichmond$2K
- Laura WarmkeRichmond$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.